日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor-Associated Macrophage (TAM)-Related Cytokines, sCD163, CCL2, and CCL4, as Novel Biomarkers for Overall Survival and Time to Treatment in Waldenstrom's Macroglobulinemia: Emphasis on Asymptomatic WM.

肿瘤相关巨噬细胞 (TAM) 相关细胞因子 sCD163、CCL2 和 CCL4 作为华氏巨球蛋白血症总体生存期和治疗时间的新型生物标志物:重点关注无症状华氏巨球蛋白血症

Gkiokas Alexandros, Papadatou-Gigante Mavra, Gkioka Annita Ioanna, Koudouna Aspasia, Tryfou Thomai M, Alexandropoulos Alexandros, Bartzi Vassiliki, Kafasi Nikolitsa, Kyrtsonis Marie-Christine